They also improve insulin sensitivity , which is often compromised during menopause
Patients who suffer from problems linked to their weight, such as type 2 diabetes, high blood pressure, or high cholesterol, could find the answer theyve been looking for in compounded Semaglutide
Mounjaro may be the better choice if: You need treatment now (retatrutide is not yet available) You prefer a medication with extensive real-world safety data Your BMI qualifies you for current GLP-1 prescriptions You have type 2 diabetes (Mounjaro has robust diabetes data) You are sensitive to GI side effects and want a well-established titration protocol Your weight loss goals are achievable with 15 to 22% body weight reduction You want insurance coverage options (available for some plans) Mounjaro is the proven, accessible, right-now option
This is actually one argument in favor of microdosing , where gastrointestinal effects are minimized while anti-inflammatory receptor activation may still occur
GLP-1 receptor agonists shortage expected until 2025 Novo Nordisk the manufacturer of several GLP-1 receptor agonists such as liraglutide and semaglutide has said that it envisages intermittent supply shortages over the next 18 months, despite running factories 24/7 to increase production
